Articles liés à Flow Cytomteric Detection of Minimal Residual Disease:...

Flow Cytomteric Detection of Minimal Residual Disease: MRD in Acute leukemia - Couverture souple

Kandeel, Eman; Kamel, Azza

 
9783659405761: Flow Cytomteric Detection of Minimal Residual Disease: MRD in Acute leukemia

Synopsis

A crucial problem for oncologist in treatment of acute leukemia is the characterization of patients who require more intensification of therapy to avert relapse. Although clinical (e.g., age, gender) and biologic (e.g., white blood cell count, immunophenotype, structural chromosomal abnormalities, and gene rearrangements) factors can be used for treatment stratification, none of these prognostic parameters is optimal. A proportion of patients with “low risk” experiences relapse, while others may receive more aggressive treatment than is necessary. Studies of minimal residual disease (MRD) focus at improving the estimation of leukemic burden during treatment. This information provides an indicator of the aggressiveness and drug sensitivity of the disease and guide in the selection of appropriate therapeutic strategies.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

À propos de l'auteur

Eman Z Kandeel MD Bone marrow transplantation Lab National cancer institute of Egypt Cairo university

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.